{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:07:49Z","timestamp":1761102469941,"version":"3.41.2"},"reference-count":30,"publisher":"XMLink","issue":"29","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003635","name":"Health Insurance Review and Assessment Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003635","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean Cancer Study Group"},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["1720150"],"award-info":[{"award-number":["1720150"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jkms.org"],"crossmark-restriction":false},"short-container-title":["J Korean Med Sci"],"DOI":"10.3346\/jkms.2021.36.e191","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:41:43Z","timestamp":1625186503000},"update-policy":"https:\/\/doi.org\/10.3346\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea"],"prefix":"10.3346","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7265-1994","authenticated-orcid":false,"given":"Do Yeun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8889-144X","authenticated-orcid":false,"given":"Hyerim","family":"Ha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Inha University Hospital, Incheon, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-8884","authenticated-orcid":false,"given":"SeungJin","family":"Bae","sequence":"additional","affiliation":[{"name":"Ewha Womans University, College of Pharmacy, Seoul, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3741-5168","authenticated-orcid":false,"given":"Jin-Hyoung","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18617","published-online":{"date-parts":[[2021]]},"reference":[{"issue":"5","key":"10.3346\/jkms.2021.36.e191_ref1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jval.2016.04.017","volume":"19","author":"Yu","year":"2016","journal-title":"Value Health"},{"key":"10.3346\/jkms.2021.36.e191_ref2","unstructured":"Medical Economics. ASCO: study examines Medicare expenditures for cancer treatments. Updated 2019. Accessed May 18, 2020.  https:\/\/www.medicaleconomics.com\/news\/asco-study-examines-medicare-expenditures-cancer-treatments"},{"issue":"5","key":"10.3346\/jkms.2021.36.e191_ref3","first-page":"1","volume":"5","author":"Renner","year":"2019","journal-title":"J Glob Oncol"},{"issue":"17","key":"10.3346\/jkms.2021.36.e191_ref4","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.ejca.2006.08.010","volume":"42","author":"Tappenden","year":"2006","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.3346\/jkms.2021.36.e191_ref5","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2217\/pgs.13.183","volume":"14","author":"Buchanan","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"8","key":"10.3346\/jkms.2021.36.e191_ref6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/annonc\/mdv249","volume":"26","author":"Cherny","year":"2015","journal-title":"Ann Oncol"},{"issue":"10","key":"10.3346\/jkms.2021.36.e191_ref7","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/annonc\/mdx310","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann Oncol"},{"issue":"23","key":"10.3346\/jkms.2021.36.e191_ref8","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","volume":"33","author":"Schnipper","year":"2015","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.3346\/jkms.2021.36.e191_ref9","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1200\/JCO.2016.68.2518","volume":"34","author":"Schnipper","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.3346\/jkms.2021.36.e191_ref10","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) with NCCN Evidence Blocks. Updated 2020. Accessed May 18, 2020.  https:\/\/www.nccn.org\/evidenceblocks\/"},{"key":"10.3346\/jkms.2021.36.e191_ref11","unstructured":"DrugAbacus. Drug Pricing Lab. Updated 2020. Accessed May 18, 2020.  https:\/\/drugpricinglab.org\/tools\/drug-abacus\/"},{"key":"10.3346\/jkms.2021.36.e191_ref12","unstructured":"Institute for Clinical and Economic Review. Updated 2020. Accessed May 18, 2020.  https:\/\/icer-review.org\/"},{"issue":"5","key":"10.3346\/jkms.2021.36.e191_ref13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(20)30139-X","volume":"21","author":"Vokinger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.3346\/jkms.2021.36.e191_ref14","unstructured":"Medigate News. Necessity of post management after drug approval and reimbursement. Updated 2020. Accessed May 18, 2020.  https:\/\/www.medigatenews.com\/news\/3188596286"},{"key":"10.3346\/jkms.2021.36.e191_ref15","unstructured":"Health Insurance Review and Assessment Service. Status of claims for paid drugs. Updated 2020. Accessed May 18, 2020.  http:\/\/www.hira.or.kr\/sViewer\/index.do?ebookSn=537"},{"key":"10.3346\/jkms.2021.36.e191_ref16","unstructured":"Korean Federation of Science and Technology Societies. What is the priority for expensive anticancer drugs?. Updated 2020. Accessed May 18, 2020.  https:\/\/www.kofst.or.kr"},{"key":"10.3346\/jkms.2021.36.e191_ref17","unstructured":"Claims for target therapy in cancer, doubled in six years. Updated 2017. Accessed May 18, 2020.  http:\/\/www.newsmp.com\/news\/articleView.html?idxno=178899"},{"key":"10.3346\/jkms.2021.36.e191_ref18","unstructured":"Medical News. Cancer patient status survey results. Updated 2020. Accessed May 18, 2020.  http:\/\/www.mdon.co.kr"},{"issue":"7","key":"10.3346\/jkms.2021.36.e191_ref19","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.clinthera.2020.05.006","volume":"42","author":"Gong","year":"2020","journal-title":"Clin Ther"},{"issue":"2","key":"10.3346\/jkms.2021.36.e191_ref20","first-page":"246","volume":"25","author":"Frois","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"issue":"2 Suppl","key":"10.3346\/jkms.2021.36.e191_ref21","first-page":"S1","volume":"170","author":"Sulmasy","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.3346\/jkms.2021.36.e191_ref22","unstructured":"OBR. Value tools at ASCO 2016: building a framework for prime time. Updated 2016. Accessed May 18, 2020.  https:\/\/www.obroncology.com\/article\/value-tools-at-asco-2016-building-a-framework-for-prime-time-2"},{"issue":"6","key":"10.3346\/jkms.2021.36.e191_ref23","first-page":"565","volume":"24","author":"Shah-Manek","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"10.3346\/jkms.2021.36.e191_ref24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1634\/theoncologist.2016-0177","volume":"21","author":"Schnipper","year":"2016","journal-title":"Oncologist"},{"issue":"24","key":"10.3346\/jkms.2021.36.e191_ref25","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1200\/JCO.2015.64.9673","volume":"34","author":"Angelis","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.3346\/jkms.2021.36.e191_ref26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejca.2017.04.029","volume":"83","author":"Sobrero","year":"2017","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.3346\/jkms.2021.36.e191_ref27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JCO.18.00729","volume":"37","author":"Cherny","year":"2019","journal-title":"J Clin Oncol"},{"year":"2016","author":"Westrich","key":"10.3346\/jkms.2021.36.e191_ref28"},{"issue":"3","key":"10.3346\/jkms.2021.36.e191_ref29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaoncol.2018.5625","volume":"5","author":"Morton","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.3346\/jkms.2021.36.e191_ref30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/JOP.2012.000827","volume":"9","author":"Kirkwood","year":"2013","journal-title":"J Oncol Pract"}],"container-title":["Journal of Korean Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jkms.org\/pdf\/10.3346\/jkms.2021.36.e191","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2021.36.e191","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2021.36.e191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:03:14Z","timestamp":1627257794000},"score":1,"resource":{"primary":{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2021.36.e191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":30,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3346\/jkms.2021.36.e191","relation":{},"ISSN":["1011-8934","1598-6357"],"issn-type":[{"type":"print","value":"1011-8934"},{"type":"electronic","value":"1598-6357"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"2021-01-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-28","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2021 The Korean Academy of Medical Sciences.","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}],"article-number":"e191"}}